In this special episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with host  Raman Sehgal, Founder & Global President at ramarketing, Laura Child, CRO Sector Lead at ramarketing, Torkel Gren, Senior Director, Technology Officer & Strategic Investments at Recipharm, Sascha Sonnenberg, Global Head of Business Development at Sharp Clinical Services, Vincent Dunne, CEO at Wasdell Group and Stephen Rode, Business Development Manager for Lonza Pharma and Biotech.

We’ll explore the impact of COVID-19 on traditional clinical trial processes to highlight how the industry has adapted. We will cover topics including ‘direct to patient treatment’ and trends that highlight a move away from the ‘norm’ in order to survive and thrive.

Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also love a positive rating! Molecule to Market is sponsored and funded by ramarketing, an international content, design and digital agency that helps companies get noticed, raise profile and generate leads in life sciences.